Zip. I respectfully disagree . MITIGATE is an independent trial with no mineral oil placebo . CV is exploratory end points . They will track this data ...how many needed Revascularization in the active arm vs control group etc
if and thats a big IF ......they kept / keep everyone on V in the active arm long enough ...event lines should clearly diverge within 2 yrs . IF ...they kept everyone on V in the active arm ...they would now be close to having 1,000 secondary prevention CAD patients on V for 2 yrs .
But since they tell us nothing ...we have no F'n idea Kiwi